Pezet A, Buteau H, Kelly P A, Edery M
INSERM U344-Endocrinologie Moléculaire, Faculté de Medecine Necker Enfants Malades, Paris, France.
Mol Cell Endocrinol. 1997 May 16;129(2):199-208. doi: 10.1016/s0303-7207(97)00063-4.
The interaction of prolactin (PRL) with its receptor leads to activation of the tyrosine kinase, Janus kinase 2 (JAK2). In the cytoplasmic juxtamembrane region, a short segment (Box 1) which is conserved in other receptors of the PRL/growth hormone (GH)/cytokine receptor family, is required for signal transduction. To assess the contribution of the different amino acids of Box 1, individual alanine substitutions of all residues, grouped substitution of four prolines (4PA mutant) and individual leucine replacement of the two last prolines (P248L and P250L mutants) were introduced. Here we show that P250L and 4PA (i) inhibit PRL-induced transactivation of a luciferase reporter governed by a beta-caseine gene promoter; (ii) decrease in JAK2 tyrosine kinase activity in biotinylated-PRL precipitates; (iii) impair the interaction between PRLR and JAK2, as evidenced by lack of co-immunoprecipitation, (iv) and prevent the activation of signal transducer and activator of transcription (Stat) as determined by absence of tyrosine phosphorylation of Stat5. Our data suggest that the Box 1 region of the PRL receptor and particularly the last proline is critical for JAK2 association and subsequent activation. These results support the notion that the tyrosine kinase JAK2 is implicated in activation of downstream protein effectors such as Stat5, which are involved in transcription of PRL-responsive genes.
催乳素(PRL)与其受体相互作用会导致酪氨酸激酶Janus激酶2(JAK2)的激活。在细胞质近膜区域,PRL/生长激素(GH)/细胞因子受体家族其他受体中保守的一个短片段(框1)是信号转导所必需的。为了评估框1中不同氨基酸的作用,对所有残基进行了单个丙氨酸替换、四个脯氨酸的分组替换(4PA突变体)以及最后两个脯氨酸的单个亮氨酸替换(P248L和P250L突变体)。我们在此表明,P250L和4PA(i)抑制PRL诱导的由β-酪蛋白基因启动子调控的荧光素酶报告基因的反式激活;(ii)降低生物素化PRL沉淀中的JAK2酪氨酸激酶活性;(iii)损害PRLR与JAK2之间的相互作用,这通过共免疫沉淀的缺乏得以证明;(iv)并阻止信号转导和转录激活因子(Stat)的激活,这通过Stat5酪氨酸磷酸化的缺失得以确定。我们的数据表明,PRL受体的框1区域,特别是最后一个脯氨酸,对于JAK2的结合及随后的激活至关重要。这些结果支持了酪氨酸激酶JAK2参与下游蛋白质效应器(如Stat5)激活的观点,Stat5参与PRL反应性基因的转录。